CSIMarket


Ultragenyx Pharmaceutical Inc   (RARE)
Other Ticker:  
 

Ultragenyx Pharmaceutical Inc

RARE's Fundamental analysis








Looking into Ultragenyx Pharmaceutical Inc growth rates, revenue grew by 8.1 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 1390

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.73 %

Ultragenyx Pharmaceutical Inc net loss decreased from $-245 millions, to $-160 millions in III. Quarter 2023,

More on RARE's Growth


Ultragenyx Pharmaceutical Inc
realized a net loss in trailing twelve months.

Ultragenyx Pharmaceutical Inc realized cash reduction of $ -4.43 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.53.


More on RARE's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 410,205
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 7.04
 Tangible Book Value (Per Share $) -2.37

Ultragenyx Pharmaceutical Inc
realized net loss in trailing twelve months.

Ultragenyx Pharmaceutical Inc realized cash outflow of $ -4.43per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.53.

Ultragenyx Pharmaceutical Inc Price to Book Ratio is at 96.15 higher than Industry Avg. of 77.57, and higher than S&P 500 Avg. of 0.01

More on RARE's Valuation

  Market Capitalization (Millions $) 3,049
  Shares Outstanding (Millions) 72
  Employees 1,000
  Revenues (TTM) (Millions $) 410
  Net Income (TTM) (Millions $) -635
  Cash Flow (TTM) (Millions $) -318
  Capital Exp. (TTM) (Millions $) -72
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 410,205
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 7.04
  Tangible Book Value (Per Share $) -2.37

  Market Capitalization (Millions $) 3,049
  Shares Outstanding (Millions) 72
  Employees 1,000
  Revenues (TTM) (Millions $) 410
  Net Income (TTM) (Millions $) -635
  Cash Flow (TTM) (Millions $) -318
  Capital Exp. (TTM) (Millions $) -72





  Ratio
   Capital Ratio (MRQ) 2.36
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.3
  Inventory Turnover Ratio (TTM) 1.36





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com